258 related articles for article (PubMed ID: 20236586)
41. Immunomodulatory effects of umbilical cord-derived mesenchymal stem cells.
Shawki S; Gaafar T; Erfan H; El Khateeb E; El Sheikhah A; El Hawary R
Microbiol Immunol; 2015 Jun; 59(6):348-56. PubMed ID: 25869421
[TBL] [Abstract][Full Text] [Related]
42. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
[TBL] [Abstract][Full Text] [Related]
43. [Factors influencing successful isolation of mesenchymal stem cells from human umbilical cord blood].
Luo F; Yang YJ; Wang X; Yu XH; Wang QH; Song JH; Liu CT; Huang R
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):509-12. PubMed ID: 17044976
[TBL] [Abstract][Full Text] [Related]
44. [Construction of recombinant porcine transforming growth factor beta1 gene lentiviral vector and its expression in bone marrow mesenchymal stem cells].
Lai J; Lin J; Lin W; Wu C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jul; 26(7):849-54. PubMed ID: 22905624
[TBL] [Abstract][Full Text] [Related]
45. [Construction of lentiviral vector containing SOX9 gene and its expression in bone marrow mesenchymal stem cells].
Xu Y; Chen L; Zhu XS; Shi Q; Liu Y; Gu Y; Tang TS
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(47):3376-80. PubMed ID: 21223759
[TBL] [Abstract][Full Text] [Related]
46. Comparison of human mesenchymal stem cells derived from adipose and cord tissue.
Choudhery MS; Badowski M; Muise A; Harris DT
Cytotherapy; 2013 Mar; 15(3):330-43. PubMed ID: 23318344
[TBL] [Abstract][Full Text] [Related]
47. Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system.
Yoshioka S; Miura Y; Iwasa M; Fujishiro A; Yao H; Miura M; Fukuoka M; Nakagawa Y; Yokota A; Hirai H; Ichinohe T; Takaori-Kondo A; Maekawa T
Int J Hematol; 2015 Aug; 102(2):218-29. PubMed ID: 26121953
[TBL] [Abstract][Full Text] [Related]
48. Construction of calcitonin gene-related peptide-modified mesenchymal stem cells and analysis of their effects on the migration and proliferation of vascular smooth muscle cells.
Chen P; He F; Liu T; Ma S; Shi B
In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):181-191. PubMed ID: 31912458
[TBL] [Abstract][Full Text] [Related]
49. [Effect of human placenta derived mesenchymal stem cells on cord blood lymphocyte transformation].
Li CD; Zhang WY; Li HL; Jiang XX; Zhang Y; Mao N
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(24):1704-7. PubMed ID: 16251077
[TBL] [Abstract][Full Text] [Related]
50. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design.
Fan X; Liu T; Liu Y; Ma X; Cui Z
Biotechnol Prog; 2009; 25(2):499-507. PubMed ID: 19319963
[TBL] [Abstract][Full Text] [Related]
51. [Lentivirus-mediated stable Fas gene silencing in human umbilical cord-derived mesenchymal stem cells].
Wang L; Zhai W; Yang X; Wang F; Li J; Li Q; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1475-80. PubMed ID: 25345945
[TBL] [Abstract][Full Text] [Related]
52. [Biological characteristics of human umbilical cord-derived mesenchymal stem cells and their differentiation into chondrogenic and osteogenic cells].
Zhao QH; Zhu JX; Wang L; Dong SH; Xia T; Tian JW
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):317-21. PubMed ID: 21419006
[TBL] [Abstract][Full Text] [Related]
53. Sciatic nerve regeneration by microporous nerve conduits seeded with glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor gene transfected neural stem cells.
Fu KY; Dai LG; Chiu IM; Chen JR; Hsu SH
Artif Organs; 2011 Apr; 35(4):363-72. PubMed ID: 21314831
[TBL] [Abstract][Full Text] [Related]
54. Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells.
Delalat B; Pourfathollah AA; Soleimani M; Mozdarani H; Ghaemi SR; Movassaghpour AA; Kaviani S
Hematology; 2009 Jun; 14(3):125-32. PubMed ID: 19490756
[TBL] [Abstract][Full Text] [Related]
55. High throughput characterization of adult stem cells engineered for delivery of therapeutic factors for neuroprotective strategies.
Sharma AD; Brodskiy PA; Petersen EM; Dagdeviren M; Ye EA; Mallapragada SK; Sakaguchi D
J Vis Exp; 2015 Jan; (95):e52242. PubMed ID: 25590859
[TBL] [Abstract][Full Text] [Related]
56. Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro.
Kang XQ; Zang WJ; Bao LJ; Li DL; Xu XL; Yu XJ
Cell Biol Int; 2006 Jul; 30(7):569-75. PubMed ID: 16716607
[TBL] [Abstract][Full Text] [Related]
57. Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency.
Qian H; Zhang X; Xu W; Zhu W; Cao H; Chen Y; Xu X; Wang M; Xie Y; Sun J
Biotechnol Appl Biochem; 2010 Feb; 55(1):53-62. PubMed ID: 19961436
[TBL] [Abstract][Full Text] [Related]
58. Osteogenic differentiation of GFP-labeled human umbilical cord blood derived mesenchymal stem cells after cryopreservation.
Liu G; Ye X; Zhu Y; Li Y; Sun J; Cui L; Cao Y
Cryobiology; 2011 Oct; 63(2):125-8. PubMed ID: 21684270
[TBL] [Abstract][Full Text] [Related]
59. Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation.
Divya MS; Roshin GE; Divya TS; Rasheed VA; Santhoshkumar TR; Elizabeth KE; James J; Pillai RM
Stem Cell Res Ther; 2012 Dec; 3(6):57. PubMed ID: 23253356
[TBL] [Abstract][Full Text] [Related]
60. [Effect of GFP-containing lentivirus infection on the expression of octamer transcription factor 4 in human umbilical cord mesenchymal stem cells].
Tang L; Chang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):292-6. PubMed ID: 23643088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
